Stem Cell market research reports by DelveInsight

• CAR T-cell Therapy - Pipeline Insight, 2022

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,000

  “ CAR T-cell Therapy - Pipeline Insight, 2022 ” report provides comprehensive insights about 300+ companies and 300+ pipeline drugs in CAR T-cell Therapy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics asses ... Read More

• CAR T-Cell Therapy for Non-Hodgkin"s lymphoma (NHL) - Epidemiology Forecast - 2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  DelveInsight's "" CAR T-Cell Therapy for Non-Hodgkin's lymphoma (NHL) - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted CAR T-Cell Therapy for Non-Hodgkin's lymphoma (NHL) epidemiology in the 7MM, i.e., the United States, EU5 (Germ ... Read More

• Allogenic iNKT cell therapy - Epidemiology Forecast - 2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  DelveInsight's "" Allogenic iNKT cell therapy - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Allogenic iNKT cell therapy epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdo ... Read More

• CAR T-Cell Therapy for Multiple Myeloma - Epidemiology Forecast - 2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  DelveInsight's "" CAR T-Cell Therapy for Multiple Myeloma - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted CAR T-Cell Therapy for Multiple Myeloma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, Franc ... Read More

• Limbal Stem Cells Deficiency (LSD) - Epidemiology Forecast - 2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  DelveInsight's "" Limbal Stem Cells Deficiency (LSD) - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Limbal Stem Cells Deficiency (LSD) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the ... Read More

• Hematopoietic Stem Cell Transplantation - Epidemiology Forecast to 2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  DelveInsight's "" Hematopoietic Stem Cell Transplantation - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Hematopoietic Stem Cell Transplantation epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, Franc ... Read More

• Nerve Repair and Regeneration- Market Insight, Competitive Landscape and Market Forecast- 2026

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 4,750

  Nerve Repair and Regeneration- Market Insight, Competitive Landscape and Market Forecast- 2026 Nerve Repair and Regeneration Market By Surgery (Direct Neuropathy [Epineural Repair, Perineural Repair, Group Fascicular Repair], Nerve Grafting [Autografts, Allografts, And Xenografts], Stem Cell Therapy ... Read More

• CD19/CD20 Bi-specific CAR-T - Epidemiology Forecast - 2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  DelveInsight's "" CD19/CD20 Bi-specific CAR-T - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted CD19/CD20 Bi-specific CAR-T epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdo ... Read More

• Stem Cell Mobilization - Epidemiology Forecast - 2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  DelveInsight's "" Stem Cell Mobilization - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Stem Cell Mobilization epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Ja ... Read More

• CAR T-Cell Therapy for Acute Lymphoblastic Leukemia (ALL) - Epidemiology Forecast - 2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  DelveInsight's "" CAR T-Cell Therapy for Acute Lymphoblastic Leukemia (ALL) - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted CAR T-Cell Therapy for Acute Lymphoblastic Leukemia (ALL) epidemiology in the 7MM, i.e., the United State ... Read More

• Chimeric Antigen Receptor (CAR) T-Cell Therapy - Epidemiology Forecast - 2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  DelveInsight's "" Chimeric Antigen Receptor (CAR) T-Cell Therapy - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Chimeric Antigen Receptor (CAR) T-Cell Therapy epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain ... Read More

< prev 1 2 next >